Prongay & Murray LLP (“GPM”) continues its investigation on
behalf of INC Research Holdings, Inc. (“INCR” or the “Company”)
investors concerning the Company and its officers’ possible violations
of federal securities law. To obtain information or aid in the
investigation, please visit the INCR page on our website at https://www.glancylaw.com/case/inc-research-holdings-inc.
On November 9, 2017, INC Research reported its first financial results
after combining with inVentiv Health. The Company’s combined results
were negatively impacted by merger-related expenses, an impairment
charge and increased amortization expenses. The price of INC Research
stock fell significantly following the announcement.
On this news, INCR’s stock price fell nearly 30%, or $16.35 per share,
to close at $41.15 per share on November 9, 2017, thereby injuring
If you purchased INCR securities, have information or would like to
learn more about these claims, or have any questions concerning this
announcement or your rights or interests with respect to these matters,
please contact Lesley F. Portnoy, Esquire, of GPM, 1925 Century Park
East, Suite 2100, Los Angeles, California 90067 at 310-201-9150,
Toll-Free at 888-773-9224, by email to [email protected],
or visit our website at www.glancylaw.com.
If you inquire by email please include your mailing address, telephone
number and number of shares purchased.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171110005609/en/